Emergency use listing of Covaxin: WHO technical advisory group decision likely today
The technical advisory group of the World Health Organization (WHO) is likely to give its decision on the emergency use listing of Bharat Biotech’s Covaxin today. The decision is much awaited across the nation as without WHO approval the vaccine will not be considered as accepted worldwide making it difficult for people who have taken the vaccine to travel.
“The World Health Organisation is very clear that we want all countries to recognise vaccines that have been given an Emergency Use Listing (EUL) by the WHO advisory process. But it’s also very important that WHO, when it makes a recommendation like that, is making that globally,” WHO Health Emergencies Programme Executive Director Dr Mike Ryan had stated last week.
Data shared by Bharat Biotech had revealed that Phase III clinical trials of Covaxin had demonstrated an efficacy rate of 77.8 per cent. The expression of interest for EUL was submitted in April by Bharat Biotech. Covid-19 vaccines manufactured by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca have been granted emergency use listing by WHO till now.
post_id:
uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
